Global investment firm Dale Ventures (www.Dale.com), led by CEO Dale W. Wood, has made an additional sizeable investment in British healthcare-tech company Medopad, joining a host of impressive backers who’ve expressed confidence in Medopad’s ability to transform healthcare in the digital age.
Medopad (www.Medopad.com) uses advanced detection of unique biomarkers to provide remote patient monitoring through digital devices, eliminating the need for certain appointments and in-person tests. Founders Dan Vahdat and Rich Khatib founded Medopad to transform healthcare from reactive to proactive, helping people with chronic, complex and rare diseases live fuller lives. The company has attracted the interest of Dale W. Wood and other leading industry investors, including pharmaceuticals giant Bayer, Hong Kong firm NWS Holdings and Chicago VC Healthbox.
“Medopad has shown tremendous growth since Dale Ventures’ initial investment and is continuing to make impressive strides toward delivering better and more personalized healthcare through the use of cutting edge biotechnology,” Dale W. Wood said. “Medopad has the ability to transform healthcare in an exceptional way that will save time, cut expenses and change lives. I’m thrilled to be among the investors whose backing will allow for further innovation in this exciting field.”
The personal, technology-driven healthcare sector has boomed as companies like Apple and Google invest in and develop wearable devices to track activity, heart rate, hydration levels and more. Medopad CEO Dan Vahdat took those technologies and transformed them into a cutting edge concept with limitless potential. Using noninvasive devices and tests, Medopad’s products are able to interpret the way users walk, talk and move to unlock health secrets that otherwise would rely on repetitive blood tests, frequent doctor’s visits and symptomatic analysis.
Through a smart phone application that can measure progressive symptoms of Parkinson’s or Alzheimer’s; wearable devices that can detect heart murmurs or gather information related to diabetes; and software that can relay data back to doctors and hospitals, Medopad is on the cusp of innovations that could change society’s approach to healthcare.
“We think there is a new category in medicine that is based on all of the data that your body generates,” Vahdat told The Economist. “The whole idea and our focus is to see if we can find signatures that will quantify your health, quantify different diseases you might be dealing with.”
Dan Vahdat first contacted Dale Ventures seeking advice for direction in Latin America. The conversation led to Dale W. Wood’s involvement in Medopad, which went on to become one of LinkedIn’s top startups in 2018 and one of London’s most-funded startups of 2019. Dale Wood’s follow-up investment will help the company continue on its trajectory of groundbreaking innovation.
About Dale Ventures
Dale Ventures is a personal investment holding group founded by serial investor Dale W. Wood. The company partners with management teams to provide the significant strategic and analytic resources needed to build and grow remarkable companies. Dale Ventures has adopted a consultative approach that harnesses the power of innovative teams to generate groundbreaking ideas, tactics, and strategies that drive growth and build long-term value.
Company Name: Dale Ventures FZE
Contact Person: Media Relations
Email: Send Email
Address:Emirates Towers Level 41 Shiekh Zayed Road P.O. Box 31303
Country: United Arab Emirates